"10.1371_journal.pmed.1000442","plos medicine","2011-06-21T00:00:00Z","Steven Riley; Kin O Kwok; Kendra M Wu; Danny Y Ning; Benjamin J Cowling; Joseph T Wu; Lai-Ming Ho; Thomas Tsang; Su-Vui Lo; Daniel K W Chu; Edward S K Ma; J S Malik Peiris","MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, United Kingdom; Department of Community Medicine and School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; Centre for Health Protection, Department of Health, Government of the Hong Kong Special Administrative Region, People's Republic of China; Hospital Authority, Hong Kong Special Administrative Region, People's Republic of China; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; HKU-Pasteur Research Center, Hong Kong Special Administrative Region, People's Republic of China","ICMJE criteria for authorship read and met: SR KOK KMW DYN BJC JTW LMH TT SVL DKWC ESKM JSMP. Agree with the manuscript's results and conclusions: SR KOK KMW DYN BJC JTW LMH TT SVL DKWC ESKM JSMP. Designed the experiments/the study: SR KOK KMW BJC JTW JSMP. Analyzed the data: SR KOK KMW DYN. Collected data/did experiments for the study: SR KOK KMW DYN LMH TT DKWC ESKM JSMP. Enrolled patients: KOK KMW. Wrote the first draft of the paper: SR. Contributed to the writing of the paper: SR KOK BJC JTW SVL JSMP.","BJC has received research funding from MedImmune Inc., a manufacturer of influenza vaccines. JSMP declares research support from GlaxoSmithKline, Baxter, Cruxell, Combinatorix, and DIVA Solutions. No other conflicts were declared. Dr J.S Malik Peiris is a PLoS Medicine Editorial Board Member.","2011","06","Steven Riley","SR",12,TRUE,NA,NA,4,1,TRUE,TRUE,FALSE,0,NA,FALSE
